Clinical experience with NuvaRing® in daily practice in Switzerland: Cycle control and acceptability among women of all reproductive ages

Author： Merki-Feld Gabriele S. Hund Martin

Publisher： Informa Healthcare

ISSN： 1473-0782

Source： The European Journal of Contraception and Reproductive Health Care, Vol.12, Iss.3, 2007-01, pp. : 240-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The combined contraceptive vaginal ring (NuvaRing®): First experience in daily clinical practice in The Netherlands

By Roumen Frans Berg Monique M. T. op ten Hoomans Eric

The European Journal of Contraception and Reproductive Health Care, Vol. 11, Iss. 1, 2006-03 ,pp. : 14-22

Informa Healthcare

Access to resources Recommend Favorite

Transvaginale hormonelle Kontrazeption: Der NuvaRing^®

By Karck U.

Der Gynäkologe, Vol. 39, Iss. 9, 2006-09 ,pp. : 712-716

Springer Publishing Company

Access to resources Recommend Favorite

Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

By Mulders T.M.T. Dieben T.O.M.

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 865-870

Elsevier

Access to resources Recommend Favorite

The contraceptive vaginal ring, NuvaRing^®, a decade after its introduction

By Roumen Frans J. M. E. Mishell Daniel R.

The European Journal of Contraception and Reproductive Health Care, Vol. 17, Iss. 6, 2012-12 ,pp. : 415-427

Informa Healthcare

Access to resources Recommend Favorite

Experience and Acceptability of Medical Abortion with Mifepristone and Misoprostol Among U.S. Women

By Beckman L.J. Harvey S.M.

Women's Health Issues, Vol. 7, Iss. 4, 1997-07 ,pp. : 253-262

Elsevier

Access to resources Recommend Favorite